Fenofibrate as a COVID-19 modifying drug: laboratory success versus real-world reality

Fenofibrate as a COVID-19 modifying drug: laboratory success versus real-world reality

Bibliographic Details
Main Authors:	Feher, M, Joy, M, Munro, N, Hinton, W, Williams, J, de Lusignan, S
Format:	Journal article
Language:	English
Published:	Elsevier 2021

Similar Items

Does real world use of liraglutide match its use in the LEADER cardiovascular outcome trial? study protocol
by: Hinton, W, et al.
Published: (2019)

Real-world prevalence of the inclusion criteria for the LEADER trial: Data from a national general practice network
by: Hinton, W, et al.
Published: (2019)

Prescribing sodium-glucose co-transporter-2 inhibitors for type 2 diabetes in primary care: influence of renal function and heart failure diagnosis
by: Hinton, W, et al.
Published: (2021)

Sodium-glucose co-transporter-2 inhibitor cardiovascular outcome trials and generalizability to English primary care
by: Hinton, W, et al.
Published: (2020)

Sodium-glucose co-transporter 2 (SGLT2) inhibitor: comparing trial data and real-world use
by: McGovern, A, et al.
Published: (2017)

Sodium-glucose co-transporter-2 (SGLT2) inhibitors: comparing trial and real world use (study protocol)
by: McGovern, A, et al.
Published: (2017)

Confined crystallization of fenofibrate in nanoporous silica
by: Dwyer, Leia Mary, et al.
Published: (2017)

Effect of fenofibrate on progression of diabetic retinopathy
by: Preiss, D, et al.
Published: (2024)

Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481].
by: Scott, R, et al.
Published: (2005)

Mortality in COVID-19 among women on hormone replacement therapy: a retrospective cohort study
by: Dambha-Miller, H, et al.
Published: (2022)

Does renal function or heart failure diagnosis affect primary care prescribing for sodium-Glucose co-transporter 2 inhibitors in type 2 diabetes?
by: Hinton, W, et al.
Published: (2020)

How generalizable are cardiovascular outcome trials of sodium-glucose co-transporter-2 inhibitors? A national database study: study protocol
by: Hinton, W, et al.
Published: (2019)

Obstructive sleep apnoea in Type 2 diabetes mellitus: increased risk for overweight as well as obese people included in a national primary care database analysis
by: Feher, M, et al.
Published: (2019)

Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study.
by: Davis, T, et al.
Published: (2011)

Effects of fenofibrate on cardiovascular events in patients with diabetes, with and without prior cardiovascular disease: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
by: Tonkin, A, et al.
Published: (2012)

Real world evidence for legacy effect of early glycaemic control in type 2 diabetes on risk of macrovascular disease
by: Whyte, M, et al.
Published: (2017)

Real-world evidence studies into treatment adherence, thresholds for intervention and disparities in treatment in people with type 2 diabetes in the UK
by: McGovern, A, et al.
Published: (2016)

A comparison of sodium-glucose co-transporter 2 inhibitor kidney outcome trial participants with a real-world chronic kidney disease primary care population
by: Forbes, AK, et al.
Published: (2024)

Preparation And Evaluation Of Fenofibrate-Gelucire 44/14 Solid Dispersions
by: Al-Dhalli, Samer
Published: (2007)

Fenofibrate improves postprandial chylomicron clearance in II B hyperlipoproteinemia.
by: Föger, B, et al.
Published: (1994)

Insulin therapy in type 3c diabetes—more common in chronic rather than acute pancreatitis
by: Hinton, W, et al.
Published: (2018)

Cholesterol-modifying drugs in COVID-19
by: Schmidt, NM, et al.
Published: (2020)

Shape Grammars Reality (SGr) : computing in the real world
by: Vlavianos, Nikolaos
Published: (2017)

Hypoglycaemia: making sense of chaotic coding in primary care computerised medical records
by: Hinton, W, et al.
Published: (2020)

Energy for tomorrows's world : the realities, the real options and the agenda for achievement /
by: 1350 World Energy Council
Published: (1993)

World class applications of six sigma : real world examples of success /
by: Antony, Jiju, et al.
Published: (2006)

Dashboards to reduce inappropriate prescribing of metformin and aspirin: a quality assurance programme in a primary care sentinel network
by: de Lusignan, S, et al.
Published: (2021)

Laser graphics in augmented reality applications for real-world robot deployment
by: Seet, Gerald Gim Lee, et al.
Published: (2021)

Glycemic control is an important modifiable risk factor for uveitis in patients with diabetes: A retrospective cohort study establishing clinical risk and ophthalmic disease burden
by: Ansari, AS, et al.
Published: (2018)

Intensification to injectable therapy in type 2 diabetes: mixed methods study (protocol).
by: De Lusignan, S, et al.
Published: (2019)

Metformin is associated with reduced risk of venous thromboembolism in Type 2 diabetes: a national primary care database study
by: Hinton, W, et al.
Published: (2019)

Effects of Fenofibrate on Cardiovascular (CVD) Events in Patients with Type 2 Diabetes Mellitus (DM) after Adjustment for Statin Use and Other Drugs: the FIELD Study
by: Simes, J, et al.
Published: (2008)

Mortality from angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers in people infected with COVID-19: a cohort study of 3.7 million people
by: Dambha-Miller, H, et al.
Published: (2022)

Techniques for characterising long COVID in real world data
by: Kostka, K, et al.
Published: (2022)

Real-world engineering : a guide to achieving career success /
by: 372427 Kamm, Lawrence J.
Published: (1991)

GLP-1 RA treatment: a benefit-risk analysis from a retrospective cohort study
by: Konstantara, E, et al.
Published: (2018)

Rapid development, real-world deployment, and evaluation of projected augmented reality applications
by: Linder, Natan
Published: (2018)

Equivalence of real-world and virtual-reality route learning: a pilot study.
by: Lloyd, J, et al.
Published: (2009)

The effect of fenofibrate therapy on laser treatment for diabetic retinopathy: a meta-analysis of randomized controlled trials
by: Preiss, D, et al.
Published: (2021)

Benchmarking in Retailing: Rhetoric versus Reality
by: Reynolds, J
Published: (2005)